|  Help  |  About  |  Contact Us

Publication : The NLRP3 Inflammasome Is Required for Protection Against Pseudomonas Keratitis.

First Author  Ramadan A Year  2023
Journal  Invest Ophthalmol Vis Sci Volume  64
Issue  2 Pages  11
PubMed ID  36749596 Mgi Jnum  J:355414
Mgi Id  MGI:7436829 Doi  10.1167/iovs.64.2.11
Citation  Ramadan A, et al. (2023) The NLRP3 Inflammasome Is Required for Protection Against Pseudomonas Keratitis. Invest Ophthalmol Vis Sci 64(2):11
abstractText  PURPOSE: The current study was designed to examine the role of the NLRP3 inflammasome pathway in the clearance of Pseudomonas aeruginosa (PA) infection in mouse corneas. METHODS: Corneas of wild type and NLRP3-/- mice were infected with PA. The severity of bacterial keratitis was graded on days 1 and 3 post-infection by slit lamp, and then corneas were harvested for: (i) bacterial enumeration, (ii) immune cell analysis by flow cytometry, (iii) immunoblotting analysis of cleaved caspase-1 and IL-1beta, and (iv) IL-1beta quantification by ELISA. In parallel experiments, severity of keratitis was examined in the wild-type mice receiving a subconjunctival injection of a highly selective NLRP3 inhibitor immediately prior to infection. RESULTS: Compared to wild type mice, NLRP3-/- mice exhibited more severe infection, as indicated by an increase in opacity score and an increase in bacterial load. The hallmark of inflammasome assembly is the activation of proinflammatory caspase-1 and IL-1beta by cleavage of their precursors, pro-caspase-1 and pro-IL-1beta, respectively. Accordingly, increased severity of infection in the NLRP3-/- mice was associated with reduced levels of cleaved forms of caspase-1 and IL-1beta and reduced IL-1beta+ neutrophil infiltration in infected corneas. Likewise, corneas of mice receiving subconjunctival injections of NLRP3 inhibitor exhibited increased bacterial load, and reduced IL-1beta expression. CONCLUSIONS: Activation of NLRP3 pathway is required for the clearance of PA infection in mouse corneas.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression